Mylan Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/14 FY 2014 – amended

ended 12/31/14 FY 2014

ended 09/30/14 Q3

ended 06/30/14 Q2

ended 03/31/14 Q1

Prospectuses and Registrations Filter

Automatic shelf registration

Automatic shelf registration

Prospectus supplement

Details of business combination or exchange offer

Prospectus supplement

Ownership Filter

Bresch Heather M

Lyons Dillon JoEllen

Cindrich Robert J

News Filter

Fourth Quarter 2014 Adjusted Diluted EPS Increases 35% to $1.05 and Full Year Adjusted Diluted EPS Up 23% to $3.56

Completes Acquisition of Abbott’s NON-U.S. Developed Markets Specialty and Branded Generics Business

Material Definitive Agreement, Termination of Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement

Shareholders Overwhelmingly Approve Agreement Implementing Acquisition of Abbott’s Non-U.S. Developed Markets Specialty and Branded Generics Business

Proxies Filter

Proxy related to merger

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC